Published in N Engl J Med on May 05, 2011
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15
Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int (2011) 2.49
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am (2013) 2.29
Absence of femoral cortical thickening in long-term bisphosphonate users: implications for atypical femur fractures. Bone (2014) 2.12
Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res (2012) 2.05
Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry. Osteoporos Int (2012) 1.84
Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res (2013) 1.66
Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician (2014) 1.63
Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis. Otol Neurotol (2012) 1.53
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res (2016) 1.50
The epidemiology of distal radius fractures. Hand Clin (2012) 1.40
Antenatal corticosteroids. CMAJ (2017) 1.39
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging (2013) 1.26
Atypical fractures do not have a thicker cortex. Osteoporos Int (2012) 1.17
Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms. Acta Biomater (2013) 1.15
Bilateral atypical femoral fractures: how much symmetry is there on imaging? Skeletal Radiol (2015) 1.14
Atypical femoral fractures bilaterally in a patient receiving denosumab. Acta Orthop (2013) 1.14
Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop (2015) 1.11
Adult Patients' Perspectives on the Benefits and Harms of Overused Screening Tests: a Qualitative Study. J Gen Intern Med (2015) 1.05
Atypical femoral fracture risk in patients treated with bisphosphonates. Arch Intern Med (2012) 1.03
Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol (2015) 0.98
Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study. Int Orthop (2014) 0.95
Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures. J Clin Endocrinol Metab (2013) 0.94
Reduced fracture risk with early corticosteroid withdrawal after kidney transplant. Am J Transplant (2011) 0.94
Bisphosphonate drug holiday: choosing appropriate candidates. Curr Osteoporos Rep (2013) 0.93
The incidence of and risk factors for developing atypical femoral fractures in Japan. J Bone Miner Metab (2014) 0.93
Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years? J Transl Med (2013) 0.92
The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective. Climacteric (2012) 0.91
Are race and sex associated with the occurrence of atypical femoral fractures? Clin Orthop Relat Res (2013) 0.91
Atypical fracture of the femur in a patient using denosumab--a case report. Acta Orthop (2014) 0.91
Prophylactic nailing of incomplete atypical femoral fractures. ScientificWorldJournal (2013) 0.91
Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary. J Bone Miner Metab (2013) 0.89
Racial/ethnic differences in hip and diaphyseal femur fractures. Osteoporos Int (2014) 0.89
Atypical femoral fractures: epidemiology, etiology, and patient management. Curr Opin Support Palliat Care (2012) 0.88
Skeletal complications of bisphosphonate use: what the radiologist should know. Br J Radiol (2012) 0.87
Dichotomous location of 160 atypical femoral fractures. Acta Orthop (2013) 0.87
Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases. Osteoporos Int (2012) 0.86
Histology of 8 atypical femoral fractures: remodeling but no healing. Acta Orthop (2014) 0.86
Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures. J Clin Endocrinol Metab (2012) 0.86
Physicians' attitudes to contemporary issues on osteoporosis management in Korea. J Bone Metab (2014) 0.85
Mechanisms of bone anabolism regulated by statins. Biosci Rep (2012) 0.85
Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta--a case report. Acta Orthop (2012) 0.84
Special Review: Accelerating fracture repair in humans: a reading of old experiments and recent clinical trials. Bonekey Rep (2013) 0.84
Osteoporosis: the emperor has no clothes. J Intern Med (2015) 0.84
Predictors of atypical femoral fractures during long term bisphosphonate therapy: a case series & review of literature. Indian J Med Res (2014) 0.84
Local bisphosphonate release versus hydroxyapatite coating for stainless steel screw fixation in rat tibiae. J Mater Sci Mater Med (2011) 0.84
Atypical femur fractures: a review of the evidence and its implication to clinical practice. Ther Adv Musculoskelet Dis (2011) 0.83
Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study. CMAJ (2012) 0.83
The osteocyte as a therapeutic target in the treatment of osteoporosis. Ther Adv Musculoskelet Dis (2014) 0.82
Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed! Acta Orthop (2012) 0.82
Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries. Osteoporos Int (2014) 0.82
Atypical femur fractures in patients receiving bisphosphonate therapy: etiology and management. Eur J Orthop Surg Traumatol (2016) 0.81
Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update. J Bone Miner Metab (2014) 0.81
Factors associated with atypical femoral fracture. Rheumatol Int (2015) 0.81
Clinical experience with intravenous zoledronic acid in the treatment of male osteoporosis: evidence and opinions. Ther Adv Musculoskelet Dis (2013) 0.81
Long-term safety concerns of antiresorptive therapy. Rheum Dis Clin North Am (2011) 0.81
Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study. Eur J Clin Pharmacol (2012) 0.80
Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation in an LXRβ-dependent mechanism. J Biol Chem (2011) 0.80
Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review. Osteoporos Int (2016) 0.80
Prodromal Symptoms in Patients with Bisphosphonate-Associated Atypical Fractures of the Femur. J Bone Miner Metab (2014) 0.79
Oral bisphosphonates are associated with increased risk of subtrochanteric and diaphyseal fractures in elderly women: a nested case-control study. BMJ Open (2013) 0.79
Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research. J Bone Metab (2015) 0.79
Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate. J Biol Chem (2016) 0.79
Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients-preliminary results. J Bone Oncol (2012) 0.79
Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice. Tissue Eng Part A (2013) 0.78
Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films. Acta Biomater (2013) 0.78
Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications. Ther Adv Chronic Dis (2015) 0.78
Short-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness. Bone (2013) 0.78
Bisphosphonate-associated peri-implant fractures: a new clinical entity? A series of 10 patients with 11 fractures. Acta Orthop (2015) 0.78
Case of femoral diaphyseal stress fracture after long-term risedronate administration diagnosed by iliac bone biopsy. Ther Clin Risk Manag (2013) 0.78
The Effect of Osteoporosis Treatments on Fatigue Properties of Cortical Bone Tissue. Bone Rep (2015) 0.78
Atypical femoral fracture in a beta-thalassemia major patient with previous bisphosphonate use: case report and a review of the literature. J Musculoskelet Neuronal Interact (2016) 0.78
Fragility fracture prevention: review from a Japanese perspective. Yonago Acta Med (2012) 0.77
Compliance with established guidelines for the radiological reporting of atypical femoral fractures. Br J Radiol (2015) 0.77
Bisphosphonate Treatment in Osteoporosis: Optimal Duration of Therapy and the Incorporation of a Drug Holiday. HSS J (2015) 0.77
Developing siRNA therapies to address osteoporosis. Ther Deliv (2013) 0.77
Are long-term bisphosphonate users a reality? Dose years for current bisphosphonate users assessed using the danish national prescription database. Osteoporos Int (2012) 0.77
Treatment of osteoporosis: current state of the art. Wien Med Wochenschr (2014) 0.77
Atypical femur fracture during bisphosphonate drug holiday: a case series. Osteoporos Int (2015) 0.76
Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: sensitivity and trim and fill studies. Genet Test Mol Biomarkers (2013) 0.76
Atypical femoral fractures related to bisphosphonate therapy. Indian J Radiol Imaging (2012) 0.76
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos (2016) 0.76
Hypophosphatasia and the risk of atypical femur fractures: a case-control study. BMC Musculoskelet Disord (2016) 0.76
Bisphosphonate-induced reductions in rat femoral bone energy absorption and toughness are testing rate-dependent. J Orthop Res (2013) 0.76
How long should we treat? Osteoporos Int (2014) 0.75
Theoretical consideration of the effect of drug holidays on BMD and tissue age. Osteoporos Int (2014) 0.75
Barriers to Effective Postmenopausal Osteoporosis Treatment: A Qualitative Study of Patients' and Practitioners' Views. PLoS One (2016) 0.75
Bisphosphonates and atypical femoral shaft fractures. N Engl J Med (2011) 0.75
Influence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritis. BMC Musculoskelet Disord (2016) 0.75
Atypical Femur Fractures in Patients Treated with Bisphosphonates: Identification, Management, and Prevention. Rambam Maimonides Med J (2016) 0.75
Decade in review-bone: Great strides made but still further to go. Nat Rev Endocrinol (2015) 0.75
Bisphosphonates and femoral fractures. Rev Obstet Gynecol (2011) 0.75
Management of atypical femoral fracture: a scoping review and comprehensive algorithm. BMC Musculoskelet Disord (2016) 0.75
Questioning the association between bisphosphonates and atypical femoral fractures. Ann N Y Acad Sci (2014) 0.75
Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea. J Bone Metab (2015) 0.75
Difference in Bone Mineral Density Change at the Lateral Femoral Cortices according to Administration of Different Bisphosphonate Agents. J Bone Metab (2016) 0.75
Total Hip Arthroplasty after Treatment of an Atypical Subtrochanteric Femoral Fracture in a Patient with Pycnodysostosis. Case Rep Orthop (2015) 0.75
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10
Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation (2009) 2.85
Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. BMJ (2009) 2.79
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med (2013) 2.73
Cardiovascular diseases and risk of hip fracture. JAMA (2009) 2.69
[Don't administer NSAID after bone surgery!]. Lakartidningen (2002) 2.54
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43
Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J (2013) 2.10
Prevention of soccer-related knee injuries in teenaged girls. Arch Intern Med (2010) 2.00
Avoid cox inhibitors after skeletal surgery! Acta Orthop Scand (2002) 2.00
Cardiac arrest in a long-distance ski race (Vasaloppet) in Sweden. J Am Coll Cardiol (2012) 1.98
Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis (2009) 1.97
Survival after hip fracture. Osteoporos Int (2005) 1.93
Unloaded rat Achilles tendons continue to grow, but lose viscoelasticity. J Appl Physiol (1985) (2007) 1.87
Local peroperative treatment with a bisphosphonate improves the fixation of total knee prostheses: a randomized, double-blind radiostereometric study of 50 patients. Acta Orthop (2007) 1.87
Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med (2014) 1.70
Simply ask them about their balance--future fracture risk in a nationwide cohort study of twins. Am J Epidemiol (2008) 1.65
Physical activity and mortality: is the association explained by genetic selection? Am J Epidemiol (2007) 1.64
Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate. Acta Orthop (2009) 1.64
Body mass index and mortality: is the association explained by genetic factors? Epidemiology (2011) 1.58
Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ (2011) 1.53
Associations of diet, supplement use, and ultraviolet B radiation exposure with vitamin D status in Swedish women during winter. Am J Clin Nutr (2007) 1.50
Etanercept does not impair healing in rat models of tendon or metaphyseal bone injury. Acta Orthop (2012) 1.50
Determining vitamin D status: a comparison between commercially available assays. PLoS One (2010) 1.49
Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. Br J Sports Med (2009) 1.48
Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis. Bone (2008) 1.48
Plasma 25-hydroxyvitamin D levels and fracture risk in a community-based cohort of elderly men in Sweden. J Clin Endocrinol Metab (2010) 1.43
Dual X-ray absorptiometry of hip, heel ultrasound, and densitometry of fingers can discriminate male patients with hip fracture from control subjects: a comparison of four different methods. J Clin Densitom (2002) 1.40
LifeGene--a large prospective population-based study of global relevance. Eur J Epidemiol (2010) 1.38
Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies. Spine (Phila Pa 1976) (2002) 1.37
Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol (2010) 1.34
Obesity is associated with inferior results after surgery for lumbar spinal stenosis: a study of 2633 patients from the Swedish spine register. Spine (Phila Pa 1976) (2013) 1.33
Presentation, outcome, and cause of septic arthritis after anterior cruciate ligament reconstruction: a case control study. Arthroscopy (2003) 1.32
Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study. PLoS One (2011) 1.26
A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants. Bone (2012) 1.25
Seasonal genetic influence on serum 25-hydroxyvitamin D levels: a twin study. PLoS One (2009) 1.25
How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop (2006) 1.24
Parecoxib impairs early tendon repair but improves later remodeling. Am J Sports Med (2004) 1.23
Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. Bone (2012) 1.23
Autologous platelets have no effect on the healing of human achilles tendon ruptures: a randomized single-blind study. Am J Sports Med (2010) 1.22
Conflicts at the heart of the FRAX tool. CMAJ (2013) 1.19
Sclerostin antibody treatment enhances metaphyseal bone healing in rats. J Bone Miner Res (2010) 1.18
Postoperative clodronate decreases prosthetic migration: 4-year follow-up of a randomized radiostereometric study of 50 total knee patients. Acta Orthop (2006) 1.18
Parathyroid hormone--a drug for orthopedic surgery? Acta Orthop Scand (2004) 1.16
Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics. Acta Orthop (2009) 1.16
Fluid pressure and flow as a cause of bone resorption. Acta Orthop (2010) 1.15
Traumatic brain injury and young onset dementia: a nationwide cohort study. Ann Neurol (2014) 1.14
Simvastatin improves fracture healing in mice. J Bone Miner Res (2002) 1.13
Smokers show less improvement than nonsmokers two years after surgery for lumbar spinal stenosis: a study of 4555 patients from the Swedish spine register. Spine (Phila Pa 1976) (2011) 1.12
Mechanical properties during healing of Achilles tendon ruptures to predict final outcome: a pilot Roentgen stereophotogrammetric analysis in 10 patients. BMC Musculoskelet Disord (2007) 1.12
Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthop (2015) 1.11
Useful tests of usefulness of new risk factors: tools for assessing reclassification and discrimination. Scand J Public Health (2011) 1.11
Tourniquet use in total knee replacement does not improve fixation, but appears to reduce final range of motion. Acta Orthop (2012) 1.11
A comparative dose-response study of cartilage-derived morphogenetic protein (CDMP)-1, -2 and -3 for tendon healing in rats. J Orthop Res (2003) 1.11
Oxidative stress and bone mineral density in elderly men: antioxidant activity of alpha-tocopherol. Free Radic Biol Med (2009) 1.11
Rat Achilles tendon healing: mechanical loading and gene expression. J Appl Physiol (1985) (2009) 1.07
Fracture risk assessment: state of the art, methodologically unsound, or poorly reported? Curr Osteoporos Rep (2012) 1.07
Long-term cadmium exposure and the association with bone mineral density and fractures in a population-based study among women. J Bone Miner Res (2011) 1.07
Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women. Bone (2012) 1.05
Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail (2010) 1.05
Long-term coffee consumption in relation to fracture risk and bone mineral density in women. Am J Epidemiol (2013) 1.04
Denosumab and atypical femoral fractures. Acta Orthop (2013) 1.04
Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats. BMC Musculoskelet Disord (2002) 1.04
The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions. Bone (2011) 1.03
A combination of bisphosphonate and BMP additives in impacted bone allografts. Acta Orthop Scand (2003) 1.03
Genetic effects on physical activity: results from the Swedish Twin Registry. Med Sci Sports Exerc (2006) 1.02
Improved healing of transected rabbit Achilles tendon after a single injection of cartilage-derived morphogenetic protein-2. Am J Sports Med (2003) 1.02
Dietary cadmium exposure and fracture incidence among men: a population-based prospective cohort study. J Bone Miner Res (2011) 1.02
Indomethacin and celecoxib improve tendon healing in rats. Acta Orthop Scand (2003) 1.00
Coffee consumption and CYP1A2 genotype in relation to bone mineral density of the proximal femur in elderly men and women: a cohort study. Nutr Metab (Lond) (2010) 0.99
Platelet concentrate increases bone ingrowth into porous hydroxyapatite. Orthopedics (2002) 0.98
PMMA particles and pressure--a study of the osteolytic properties of two agents proposed to cause prosthetic loosening. J Orthop Res (2003) 0.98
Paradoxical Sost gene expression response to mechanical unloading in metaphyseal bone. Bone (2013) 0.98
Circulating levels of persistent organic pollutants associate in divergent ways to fat mass measured by DXA in humans. Chemosphere (2011) 0.98
Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling. A bone chamber study in rats. BMC Musculoskelet Disord (2006) 0.97
Fusion Surgery for Lumbar Spinal Stenosis. N Engl J Med (2016) 0.97
The total costs of a displaced femoral neck fracture: comparison of internal fixation and total hip replacement. A randomised study of 146 hips. Int Orthop (2005) 0.97
Surface-bound bisphosphonates enhance screw fixation in rats--increasing effect up to 8 weeks after insertion. Acta Orthop (2007) 0.97
Wnt signaling and orthopedics, an overview. Acta Orthop (2011) 0.95
Healing of human Achilles tendon ruptures: radiodensity reflects mechanical properties. Knee Surg Sports Traumatol Arthrosc (2013) 0.95
CDMP-2 induces bone or tendon-like tissue depending on mechanical stimulation. J Orthop Res (2002) 0.95
[Cyclooxygenase inhibitors inhibit bone formation in human beings]. Lakartidningen (2002) 0.95
Achilles tendon healing in rats is improved by intermittent mechanical loading during the inflammatory phase. J Orthop Res (2011) 0.94
Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats. Acta Orthop Scand (2002) 0.94
Locally applied Simvastatin improves fracture healing in mice. BMC Musculoskelet Disord (2007) 0.94
Rinsing morselized allografts improves bone and tissue ingrowth. Clin Orthop Relat Res (2003) 0.94
Increased rate of bone loss at the femoral neck in patients with chronic liver disease. Eur J Gastroenterol Hepatol (2002) 0.94
Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats. Acta Orthop (2011) 0.94
Early controlled tension improves the material properties of healing human achilles tendons after ruptures: a randomized trial. Am J Sports Med (2013) 0.94
Different effects of indomethacin on healing of shaft and metaphyseal fractures. Acta Orthop (2014) 0.94
Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing. J Orthop Res (2013) 0.93
Systemic zoledronate precoating of a bone graft reduces bone resorption during remodeling. Acta Orthop (2006) 0.93
Independent and additive stimulation of tendon repair by thrombin and platelets. Acta Orthop (2006) 0.93
Bisphosphonate coating on titanium screws increases mechanical fixation in rat tibia after two weeks. J Biomed Mater Res A (2008) 0.93
Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone. J Oral Pathol Med (2012) 0.93
Black holes in bone - irresistible attractors of foreign materials? Acta Orthop (2009) 0.93
Type I collagen alpha1 Sp1 polymorphism and the risk of cruciate ligament ruptures or shoulder dislocations. Am J Sports Med (2008) 0.92